Related Experiment Video
Updated: May 17, 2026
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Negative affect differentiation and adherence during treatment for thalassemia
Karin G Coifman1, Gail S Ross, Dorothy Kleinert
1Department of Psychology, Kent State University, P.O. Box 5190, Kent, OH, 44242-0001, USA, kcoifman@kent.edu.
International Journal of Behavioral Medicine
|October 23, 2012
Summary
Understanding and differentiating negative emotions improves treatment adherence in adults with thalassemia. This emotional awareness can lead to better health behaviors and outcomes in chronic illness management.
Area of Science:
- Psychology
- Medical Adherence
- Emotional Processing
Background:
- Excessive negative affect negatively impacts chronic illness treatment adherence and morbidity.
- Research on the benefits of awareness of negative emotional experiences during treatment is limited.
Purpose of the Study:
- To examine the association between negative affect differentiation and treatment adherence in adult thalassemia patients.
- Investigate if the ability to distinguish between negative emotions relates to adherence.
Main Methods:
- Negative affect differentiation assessed via a 12-16 week treatment diary.
- Treatment adherence measured by attendance at routine screenings over 12 months.
- Study included 32 adult patients with transfusion-dependent thalassemia.
Main Results:
- Negative affect differentiation showed a significant positive association with greater treatment adherence.
- This association remained significant after controlling for disease burden and psychological distress.
Conclusions:
- Differentiated processing of negative emotions during illness may promote adaptive treatment behaviors.
- This finding suggests a potential new research and intervention target for improving chronic illness treatment adherence.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...